AC-0676 by Accutar Biotechnology for Follicular Lymphoma: Likelihood of Approval
Related Articles
National Park Service meets with township a year after raising concerns about River Pointe project
More than a year after the National Park Service first raised concerns about the River Pointe Commerce Park project — one of the largest developments…
Power line from N.M. to Southern Arizona wins final US approval
Federal regulators have given final clearance to a new power line connecting a massive wind farm in New Mexico to the grid in Arizona by…
Nbt Bancorp Inc. Receives Regulatory Approval, Announces Date For Merger With Salisbury Bancorp, Inc.
(MENAFN- GlobeNewsWire – Nasdaq) ATTENTION: FINANCIAL AND BUSINESS EDITORS NORWICH, N.Y., July 10, 2023 (GLOBE NEWSWIRE) — NBT Bancorp Inc. (“NBT” or the“Company”) (NASDAQ: NBTB)…
Nbt Bancorp Inc. Receives Regulatory Approval, Announces Date For Merger With Salisbury Bancorp, Inc.
(MENAFN- GlobeNewsWire – Nasdaq) ATTENTION: FINANCIAL AND BUSINESS EDITORS NORWICH, N.Y., July 10, 2023 (GLOBE NEWSWIRE) — NBT Bancorp Inc. (“NBT” or the“Company”) (NASDAQ: NBTB)…
Nbt Bancorp Inc. Receives Regulatory Approval, Announces Date For Merger With Salisbury Bancorp, Inc.
(MENAFN- GlobeNewsWire – Nasdaq) ATTENTION: FINANCIAL AND BUSINESS EDITORS NORWICH, N.Y., July 10, 2023 (GLOBE NEWSWIRE) — NBT Bancorp Inc. (“NBT” or the“Company”) (NASDAQ: NBTB)…
Responses